Michael M. Derkacz
Directeur Général chez BRAEBURN INC.
Profil
Michael M.
Derkacz is currently the President, Chief Executive Officer & Director at Braeburn, Inc. He previously worked as a Vice President at Cephalon, Inc., Vice President & General Manager-CNS at Teva Pharmaceutical Industries Ltd., and Senior Vice President at Auspex Pharmaceuticals, Inc. He received his undergraduate degree from The University of Texas at Austin in 1991.
Postes actifs de Michael M. Derkacz
| Sociétés | Poste | Début |
|---|---|---|
| BRAEBURN INC. | Directeur Général | 05/06/2017 |
Anciens postes connus de Michael M. Derkacz
| Sociétés | Poste | Fin |
|---|---|---|
| AUSPEX PHARMACEUTICALS INC | Corporate Officer/Principal | - |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Corporate Officer/Principal | - |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | - |
Formation de Michael M. Derkacz
| The University of Texas at Austin | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| Entreprise privées | 3 |
|---|---|
Auspex Pharmaceuticals, Inc.
 Auspex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Auspex Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm focuses on the development and commercialization of novel medicines for the treatment of orphan diseases. The company was founded by Sepehr Sarshar, Thomas G. Gant and Manouchehr M. Shahbaz on February 28, 2001 and is headquartered in San Diego, CA. | Health Technology |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
Braeburn, Inc.
 Braeburn, Inc. Miscellaneous Commercial ServicesCommercial Services Braeburn, Inc. manufactures pharmaceutical products. It focuses on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain and schizophrenia. The firm develops Probuphine for the treatment of adult patients with opioid dependence. The company was founded in 2012 and is headquartered in Princeton, NJ. | Commercial Services |
